Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
When it comes to recovering a failed Exchange Server, you should look into the best solutions to minimize the impact on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results